First Turn Management »

Intra Cellular Therapies shares owned by First Turn Management

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by First Turn Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $25M 294k 83.52
2024-09-30 $19M 255k 73.17
2024-03-31 $14M 207k 69.20
2023-12-31 $16M 217k 71.62

More positions owned by First Turn Management

Insmed Com Par $.01 (INSM)
Mirum Pharmaceuticals (MIRM)
United Therapeutics Corporation (UTHR)
Merus N V (MRUS)
Nuvalent Inc-a (NUVL)
Xenon Pharmaceuticals (XENE)
Bridgebio Pharma (BBIO)
Revolution Medicines (RVMD)
Ascendis Pharma A/s Sponsored Adr (ASND)
Argenx Se Sponsored Adr (ARGX)
Disc Medicine (IRON)
Oric Pharmaceuticals (ORIC)
Arcellx Common Stock (ACLX)
Neurocrine Biosciences (NBIX)
Abivax Sa Sponsored Ads (ABVX)

View all positions for First Turn Management

Top funds holding Intra Cellular Therapies

Huntington National Bank

View all funds holding Intra Cellular Therapies